trilostane sold brand name vetoryl among others medication used treatment cushings syndrome conns syndrome postmenopausal breast cancer withdrawn use humans united states subsequently approved use veterinary medicine treat cushings syndrome taken trilostane used treatment cushings syndrome hypercortisolism conns syndrome hyperaldosteronism postmenopausal breast cancer used treat breast cancer trilostane administered combination corticosteroid prevent glucocorticoid trilostane used treatment cushings syndrome dogs safety effectiveness trilostane indication shown several success measured improvements blood test results physical symptoms normalized appetite activity level decreased panting thirst trilostane used pregnant trilostane given dog side effects trilostane conjunction corticosteroid humans include gastrointestinal side effects like gastritis nausea vomiting nonsteroidal antiinflammatory drugs nsaids may decrease incidence diarrhea serious gastrointestinal side effects trilostane alone combination nsaid like peptic ulcer erosive gastritis gastric perforation hematemesis melena may occur reversible granulocytopenia transient oral paresthesia may occur trilostane steroidogenesis specifically inhibitor dehydrogenase result action trilostane blocks conversion including pregnenolone dehydroepiandrosterone dhea androstenediol including progesterone androstenedione testosterone consequently trilostane inhibits production classes steroid hormones including androgens estrogens progestogens glucocorticoids mechanism action trilostane cushings syndrome conns syndrome inhibiting production corticosteroids cortisol aldosterone adrenal trilostane also used abortifacient due inhibition progesterone trilostane aromatase inhibitor hence inhibit conversion androgens like androstenedione testosterone estrogens like estrone however trilostane may nonetheless inhibit estrogen synthesis inhibiting androgen addition steroidogenesis inhibition trilostane found act noncompetitive antiestrogen via direct presumably allosteric interactions estrogen effectiveness trilostane postmenopausal breast cancer may relate apparent antiestrogenic trilostane also found act agonist androgen use men prostate cancer may warrant trilostane metabolized major metabolite trilostane conversion trilostane reversible suggesting trilostane undergo interconversion circulates higher levels trilostane active trilostane elimination halflives trilostane hours compounds cleared blood within hours dose excreted trilostane also known synthetic androstane steroid derivative androstane derivatives like trilostane prepared testosterone fourstep synthesiscitation needed trilostane withdrawn human use united states market april continued available united kingdom use humans brand name modrenal treatment cushings disease breast cancer humans eventually discontinued country trilostane approved united states treatment cushings disease hyperadrenocorticism dogs brand name available prescription united kingdom dogs vetoryl brand name time approved united drug also used treat skin disorder alopecia x trilostane first drug approved treat pituitary adrenaldependent cushings dogscitation needed one drug anipryl veterinary brand name selegiline fdaapproved treat cushings disease dogs treat uncomplicated pituitarydependent previous treatment disease use mitotane brand name lysodren number compounding pharmacies united states sell trilostane dogscitation needed since united states approval vetoryl december compounding pharmacies longer able use bulk drug product compounding purposes must prepare compounded drug trilostane generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved name jantooltip japanese accepted developmental code name trilostane marketed number brand names including desopan modrastane modrenal trilox vetoryl oncovet tl trilostane available veterinary use many countries throughout httpsenwikipediaorgwikitrilostane